11/11/2024  22:10:00 Diferencia -0.33 Volumen Bid11:23:14 Ask11:23:14 Capitalización de mecado Dividendo A. P/E Ratio
92.28USD -0.36% 1.17 millones
Volumen de negocios: 64.88 millones
91.14Volumen de oferta: 400 91.24Tamaño/ Volumen/ Formato de Ask: 400 45.79 mil millonesUSD 0.31% 46.28

Descripción de negocio

Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning more than seven decades, the company offers the broadest portfolio of products to enhance sight and improve people’s lives. Its Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. More than 20,000 associates are enhancing the quality of life through innovative products, partnerships with eye care professionals and programs that advance access to quality eye care.
 

Consejo de gestión & Consejo de supervisión

CEO
David Endicott
Consejo de gestión
Tim Stonesifer, Ian Bell, Laurent Attias, Rajkumar Narayanan, Sergio Duplan, Sue-Jean Lin
Consejo de supervisión
F. Michael Ball, Arthur Cummings, D. Keith Grossman, David J. Endicott, Dieter Spälti, Ines Pöschel, Karen May, Lynn Bleil, Scott Maw, Thomas Glanzmann, Raquel C. Bono
 

Datos de la empresa

Nombre: Alcon Inc.
Dirección: Chemin de Blandonnet 8,CH-1214 Vernier, Geneva
Teléfono: +41-589-112-110
Fax: -
E-mail: investor.relations@alcon.com
Internet: https://www.alcon.com
Industria: Healthcare
Sector: Medical Products
Subsector: Advanced Medical Devices
Fin del año financiero: 31/12
Acciones de libre circulación: 98.64%
Fecha de OPI: 09/04/2019

Relación con inversores

Nombre: Allen Trang
IR teléfono: +41 589 112 110
IR-fax: -
IR e-mail: investor.relations@alcon.com

Calendario de la empresa

CW 46 | 13/11/2024 Interim Report 3rd Quarter/9 Months
 

Accionistas mayoritarios

Otros
 
79.08%
Cede & Co
 
20.92%